ClassID:

94701

C07D265/30 - page 2 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms 1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Recent Application in this class:
#301
20180072660
2018-03-15

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

#302
20180071304
2018-03-15

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

#303
20180065942
2018-03-08

Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparing

#304
20180016227
2018-01-18

PROCESS FOR THE SYNTHESIS OF DIFLUOROMETHYL ETHER-BASED COMPOUNDS

#305
20180000805
2018-01-04

Cyclopropylamines as LSD1 inhibitors

#306
20170362342
2017-12-21

Method for preparing cellulose dope

#307
20170349544
2017-12-07

Ethynylbenzene derivatives

#308
20170348324
2017-12-07

DERIVATIVES OF BETULIN

#309
20170334882
2017-11-23

Hepatitis B antiviral agents

#310
20170334874
2017-11-23

Piperazine carbamates and methods of making and using same

#311
20170334851
2017-11-23

Compounds as anti-tubercular agents

#312
20170327505
2017-11-16

Synthesis of copanlisib and its dihydrochloride salt

#313
20170327459
2017-11-16

Neprilysin inhibitors

#314
20170320838
2017-11-09

Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists

#315
20170313713
2017-11-02

Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors

#316
20170313649
2017-11-02

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#317
20170305945
2017-10-26

Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins

#318
20170298076
2017-10-19

Pharmacologically active compounds

#319
20170290836
2017-10-12

Arylquinazolines

#320
20170283365
2017-10-05

Nitrogen containing hydrofluoroethers and methods of using same

#321
20170260130
2017-09-14

Benzimidazole Inhibitors of the Sodium Channel

#322
20170252356
2017-09-07

Compounds and compositions for treating HIV with derivatives of Betulin

#323
20170233377
2017-08-17

Heterocyclic compounds as NaV channel inhibitors and uses thereof

#324
20170231999
2017-08-17

IDO inhibitors

#325
20170217986
2017-08-03

HIV protease inhibitors

#326
20170210912
2017-07-27

Hydrophilic oil repellent and production method of same, surface coating material, coating film, resin composition, oil-water separation filter material, and porous body

#327
20170210701
2017-07-27

Substituted cyano cycloalkyl penta-2,4-dienes, cyano cycloalkyl pent-2-en-4-ynes, cyano heterocyclyl penta-2,4-dienes and cyano heterocyclyl pent-2-en-4-ynes as active substances against abiotic plant stress

#328
20170210643
2017-07-27

Oil-water separation apparatus and drainage system

#329
20170198287
2017-07-13

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

#330
20170198186
2017-07-13

Hydrofluoroether olefins and methods of using same

#331
20170190680
2017-07-06

Cyclopropylamine compounds as histone demethylase inhibitors

#332
20170183318
2017-06-29

AMIDE COMPOUNDS, METHODS FOR PREPARATION, AND USE THEREOF AS AGENTS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY RNA- AND/OR DNA-CONTAINING VIRUSES, AND CONCOMITANT DISEASES

#333
20170174699
2017-06-22

Compounds for the treatment of cancer and inflammatory disease

#334
20170166542
2017-06-15

Process for the synthesis of sulfones and sulfonamides

#335
20170158652
2017-06-08

Process for preparing substituted 5-fluoro-1H-pyrazolopyridines

#336
20170152230
2017-06-01

Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same

#337
20170107203
2017-04-20

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

#338
20170107202
2017-04-20

Compounds useful as immunomodulators

#339
20170081303
2017-03-23

Treprostinil derivative compounds and methods of using same

#340
20170022185
2017-01-26

Decarboxylative cross-coupling and applications thereof

#341
20170015619
2017-01-19

Neprilysin inhibitors

#342
20160368889
2016-12-22

Treprostinil derivative compounds and methods of using same

#343
20160347719
2016-12-01

(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide

#344
20160347708
2016-12-01

Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides

#345
20160332968
2016-11-17

Antidiabetic compounds

#346
20160326126
2016-11-10

Amyloid targeting agents and methods of using the same

#347
20160318947
2016-11-03

Pharmacologically active compounds

#348
20160311786
2016-10-27

HIV protease inhibitors

#349
20160311759
2016-10-27

Lipids and lipid compositions for the delivery of active agents

#350
20160304475
2016-10-20

Methods for producing viloxazine salts and novel polymorphs thereof

#351
20160297810
2016-10-13

Viral replication inhibitors

#352
20160297754
2016-10-13

N-substituted benzamides and methods of use thereof

#353
20160296527
2016-10-13

HIV protease inhibitors

#354
20160289718
2016-10-06

Process for the preparation of chiral 2-aryl morpholines

#355
20160289171
2016-10-06

IDO inhibitors

#356
20160272602
2016-09-22

Piperazine carbamates and methods of making and using same

#357
20160264596
2016-09-15

Substituted benzamides

#358
20160263566
2016-09-15

Phosphine ligands for catalytic reactions

#359
20160237040
2016-08-18

Benzathine analogs

#360
20160235747
2016-08-18

FBXO3 inhibitors

#361
20160229830
2016-08-11

Glucosylceramide synthase inhibitors for the treatment of diseases

#362
20160220547
2016-08-04

Cyclopropylamines as LSD1 inhibitors

#363
20160194307
2016-07-07

Compounds useful as immunomodulators

#364
20160193217
2016-07-07

Therapeutic agent for ophthalmic disease

#365
20160175828
2016-06-23

N-heterocyclic carbene type palladium catalyst and its preparation method as well as applications

#366
20160168180
2016-06-16

Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins

#367
20160152581
2016-06-02

5,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE)

#368
20160151376
2016-06-02

Bisaryl (thio)morpholine derivatives as S1P modulators

#369
20160145247
2016-05-26

Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof

#370
20160145220
2016-05-26

Nitrogen-containing saturated heterocyclic compound

#371
20160145195
2016-05-26

Nitrogen containing hydrofluoroethers and methods of making same

#372
20160131972
2016-05-12

Onium salt compound, resist composition, and pattern forming process

#373
20160083371
2016-03-24

1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity

#374
20160083354
2016-03-24

Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same

#375
20160083348
2016-03-24

Compounds and uses thereof for the modulation of hemoglobin

#376
20160083343
2016-03-24

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

#377
20160075638
2016-03-17

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#378
20160052898
2016-02-25

NOVEL COMPOUNDS

#379
20160039745
2016-02-11

Histone deacetylase inhibitors and compositions and methods of use thereof

#380
20160016939
2016-01-21

Heterocyclic inhibitors of the sodium channel

#381
20160009671
2016-01-14

Process for preparing substituted 5-fluoro-1H-pyrazolopyridines

#382
20150376128
2015-12-31

Neprilysin inhibitors

#383
20150361050
2015-12-17

(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide

#384
20150361032
2015-12-17

Benzimidazole inhibitors of the sodium channel

#385
20150361031
2015-12-17

STAT3 inhibitor

#386
20150360215
2015-12-17

Phosphine ligands for catalytic reactions

#387
20150353569
2015-12-10

Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof

#388
20150353568
2015-12-10

Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof

#389
20150353567
2015-12-10

Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof

#390
20150353469
2015-12-10

Derivatives of the sinapinic acid

#391
20150344408
2015-12-03

Hydroxy aliphatic substituted phenyl aminoalkyl ether derivatives

#392
20150336972
2015-11-26

Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof

#393
20150307475
2015-10-29

Autotaxin inhibitors

#394
20150284404
2015-10-08

Benzyl sulfonamide compounds useful as MoGAT-2 inhibitors

#395
20150266862
2015-09-24

Heterocyclic compounds as NaV channel inhibitors and uses thereof

#396
20150259324
2015-09-17

Hepatitis B antiviral agents

#397
20150259282
2015-09-17

Potassium channel blockers

#398
20150252038
2015-09-10

Substituted benzamides and methods of use thereof

#399
20150246906
2015-09-03

Acetamide derivatives

#400
20150246063
2015-09-03

ATX modulating agents

#401
20150239857
2015-08-27

(Thio)morpholine derivatives as S1P modulators

#402
20150232459
2015-08-20

Renin inhibitor

#403
20150231048
2015-08-20

Method of Maintaining Oral Health in Animals

#404
20150225335
2015-08-13

Hydroxamic acid derivative

#405
20150224108
2015-08-13

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

#406
20150218144
2015-08-06

Substituted phenylcarbamate compounds

#407
20150218142
2015-08-06

Derivatives of Betulin

#408
20150210626
2015-07-30

Cycloalkyl-diamines

#409
20150191457
2015-07-09

Bisaryl (thio)morpholine derivatives as S1P modulators

#410
20150166503
2015-06-18

Treprostinil derivative compounds and methods of using same

#411
20150152126
2015-06-04

Phosphine ligands for catalytic reactions

#412
20150152073
2015-06-04

Hepatitis B antiviral agents

#413
20150152041
2015-06-04

Benzathine analogs

#414
20150133430
2015-05-14

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

#415
20150126735
2015-05-07

Viloxazine compositions

#416
20150080408
2015-03-19

Substituted biphenyl amides as P2Xand P2Xantagonists

#417
20150080369
2015-03-19

Compounds

#418
20150080350
2015-03-19

Bumetanide analogs, compositions and methods of use

#419
20150073140
2015-03-12

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

#420
20150057443
2015-02-26

Cycloalkyl Amine Compounds

#421
20150038498
2015-02-05

Thrombin inhibitors

#422
20140371316
2014-12-18

DERIVATIVES OF PHENOXYISOBUTYRIC ACID

#423
20140371176
2014-12-18

Cyclopropylamines as LSD1 inhibitors

#424
20140315926
2014-10-23

Process for preparing substituted 5-fluoro-1H-pyrazolopyridines

#425
20140309192
2014-10-16

MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO

#426
20140275008
2014-09-18

Compounds and uses thereof for the modulation of hemoglobin

#427
20140256730
2014-09-11

Treprostinil derivative compounds and methods of using same

#428
20140256715
2014-09-11

Oxazine derivatives and their use in the treatment of disease

#429
20140227161
2014-08-14

System and method for extraction of chemicals from lignocellulosic materials

#430
20140221645
2014-08-07

Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins

#431
20140221337
2014-08-07

Potassium channel blockers

#432
20140213784
2014-07-31

Method for the preparation of substituted oxazolidinones

#433
20140200197
2014-07-17

HIV protease inhibitors

#434
20140187531
2014-07-03

Apoptosis promoters

#435
20140179665
2014-06-26

Hepatitis B antiviral agents

#436
20140178337
2014-06-26

Hepatitis B antiviral agents

#437
20140171404
2014-06-19

Autotaxin inhibitors

#438
20140148452
2014-05-29

Morpholino compounds, uses and methods

#439
20140121371
2014-05-01

PROCESSES AND REAGENTS FOR MAKING DIARYLIODONIUM SALTS

#440
20140100224
2014-04-10

NEUROTROPHIN MIMETICS AND USES THEREOF

#441
20140094455
2014-04-03

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

#442
20140066446
2014-03-06

2,5-disubstituted arylsulfonamide CCR3 antagonists

#443
20140058101
2014-02-27

Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions

#444
20140057918
2014-02-27

Methods of Use for Monomethyl Fumarate and Prodrugs Thereof

#445
20140038945
2014-02-06

PIPERAZINE PDE4 INHIBITORS AND USES THEREOF

#446
20140024645
2014-01-23

Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists

#447
20140018393
2014-01-16

Cyclopropylamines as LSD1 inhibitors

#448
20140018341
2014-01-16

Method of inhibiting tau phosphorylation

#449
20140011807
2014-01-09

Nitrogen-containing saturated heterocyclic compound

#450
20130345213
2013-12-26

Substituted morpholines as modulators for the calcium sensing receptor

#451
20130324719
2013-12-05

Process for preparation of Linezolid and its novel intermediates

#452
20130317001
2013-11-28

N-substituted benzamides and methods of use thereof

#453
20130317000
2013-11-28

N-substituted benzamides and methods of use thereof

#454
20130310383
2013-11-21

1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity

#455
20130289034
2013-10-31

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#456
20130281452
2013-10-24

Substituted 4-aminobenzamides as KCNQ2/3 modulators

#457
20130231323
2013-09-05

Ethynylbenzene derivatives

#458
20130217876
2013-08-22

Phosphine ligands for catalytic reactions

#459
20130203753
2013-08-08

Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use

#460
20130203752
2013-08-08

Phenylmorpholines and analogues thereof

#461
20130203745
2013-08-08

Bisaryl (thio)morpholine derivatives as S1P modulators

#462
20130203738
2013-08-08

Use of compound binding to mSin3B that specifically binds to neuron restrictive silencer factor (NRSF)

#463
20130203712
2013-08-08

Methods for inhibiting muscle atrophy

#464
20130202653
2013-08-08

3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immuno stimulant activity

#465
20130196984
2013-08-01

3-AMINO-5-PHENYL-56-DIHYDRO-2H-[1,4]OXAZINES

#466
20130190488
2013-07-25

Apoptosis promoters

#467
20130190288
2013-07-25

Benzyl sulfonamide derivatives as RORc modulators

#468
20130184238
2013-07-18

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#469
20130178457
2013-07-11

Cannabinoid receptor modulators

#470
20130165443
2013-06-27

Pyridinyl amides as P2X3 and P2X2/3 inhibitors

#471
20130150574
2013-06-13

Process for the manufacture of chiral catalysts and their salts

#472
20130143900
2013-06-06

Process for preparing substituted 5-fluoro-1H-pyrazolopyridines

#473
20130109683
2013-05-02

5,6-DIHYDRO-2H-[1,4]OXAZIN-3-YL-AMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

#474
20130102780
2013-04-25

Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof

#475
20130102779
2013-04-25

Substituted tetracycline compounds

#476
20130102610
2013-04-25

Phenoxy acetic acids as PPAR delta activators

#477
20130096127
2013-04-18

Substituted aminopropionic derivatives as neprilysin inhibitors

#478
20130096105
2013-04-18

Arylsulfonamide based matrix metalloprotease inhibitors

#479
20130089624
2013-04-11

Compounds useful as inhibitors of ATR kinase

#480
20130072677
2013-03-21

Hydroxamic acid derivative

#481
20130072488
2013-03-21

Aralkyl diamine derivatives and uses thereof as antidepressants

#482
20130065889
2013-03-14

2,5-disubstituted arylsulfonamide CCR3 antagonists

#483
20130023535
2013-01-24

METHOD OF PREVENTING AND/OR TREATING DIABETIC NEUROPATHY

#484
20130012701
2013-01-10

Quaternary heteroatom containing compounds

#485
20130005717
2013-01-03

3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity

#486
20120316173
2012-12-13

Compounds which modulate the CB2 receptor

#487
20120316165
2012-12-13

Substituted benzamide derivatives

#488
20120309965
2012-12-06

Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins

#489
20120289504
2012-11-15

Benzoimidazole compounds and uses thereof

#490
20120264762
2012-10-18

Heterocyclic Compounds as CCR2 Antagonists

#491
20120258954
2012-10-11

Arylsulfonamide based matrix metalloprotease inhibitors

#492
20120245348
2012-09-27

Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions

#493
20120245172
2012-09-27

Heterocyclic amine derivatives

#494
20120238560
2012-09-20

Oxazine Derivatives and their Use in the Treatment of Neurological Disorders

#495
20120226041
2012-09-06

CATALYSTS AND BORONATE ESTERS

#496
20120225881
2012-09-06

Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds

#497
20120220552
2012-08-30

(Thio)morpholine derivatives as S1P modulators

#498
20120214806
2012-08-23

3-AMINO-5-PHENYL-5,6-DIHYDRO-2H-[1,4]OXAZINES

#499
20120196863
2012-08-02

1,4 oxazines as BACE1 and/or BACE2 inhibitors

#500
20120184540
2012-07-19

1,4 oxazines as BACE1 and/or BACE2 inhibitors

#501
20120157497
2012-06-21

Compounds having analgesic and/or immunostimulant activity

#502
20120122934
2012-05-17

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#503
20120122784
2012-05-17

Calcium sensing receptor modulating compounds and pharmaceutical use thereof

#504
20120122678
2012-05-17

Phenoxy substituted phenylamidine derivatives and their use as fungicides

#505
20120108573
2012-05-03

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

#506
20120101080
2012-04-26

Composition for treatment of tuberculosis

#507
20120071654
2012-03-22

ARYL ANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEPTOR AGONISTS

#508
20120065169
2012-03-15

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

#509
20120046272
2012-02-23

Novel Therapeutic Compounds

#510
20120016120
2012-01-19

Process for producing 2-hydroxymethylmorpholine salt

#511
20120015947
2012-01-19

Cyclic hydroxylamine as psychoactive compounds

#512
20120004227
2012-01-05

Cyclohexane derivative having NPY Y5 receptor antagonism

#513
20120004225
2012-01-05

BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#514
20110313159
2011-12-22

Camphor-derived β-amino alcohol compounds, method for manufacturing the same and asymmetric addition of organozinc to aldehydes using the same

#515
20110306600
2011-12-15

NOVEL THERAPEUTIC COMPOUNDS

#516
20110306542
2011-12-15

GLP-1 receptor stabilizers and modulators

#517
20110301346
2011-12-08

Process for the preparation and purification of amorolfine hydrochloride

#518
20110288094
2011-11-24

1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity

#519
20110288076
2011-11-24

Acetanilide sphingosine-1-phosphate receptor antagonists

#520
20110275797
2011-11-10

N-acyl anthranilic acid derivative or salt thereof

#521
20110268671
2011-11-03

Method of Maintaining Oral Health in Animals

#522
20110257392
2011-10-20

INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF

#523
20110256129
2011-10-20

Apoptosis promoters

#524
20110251385
2011-10-13

INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF

#525
20110251198
2011-10-13

Methods for producing viloxazine salts and novel polymorphs thereof

#526
20110245244
2011-10-06

Phenyl propionic acids as PPAR delta activators

#527
20110230479
2011-09-22

NEUROTROPHIN MIMETICS AND USES THEREOF

#528
20110217654
2011-09-08

Latent acids and their use

#529
20110172195
2011-07-14

AQUAPORIN MODULATORS AND METHODS OF USING THEM FOR THE TREATMENT OF EDEMA AND FLUID IMBALANCE

#530
20110171143
2011-07-14

Method of maintaining oral health in animals

#531
20110166348
2011-07-07

NOVEL SALT OF MORPHOLINE DERIVATIVE

#532
20110152268
2011-06-23

NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING NOCICEPTIVE PAIN

#533
20110152245
2011-06-23

Substituted benzamides

#534
20110144112
2011-06-16

Apoptosis promoters

#535
20110136820
2011-06-09

Heterocyclic Compounds as CCR2 Antagonists

#536
20110136797
2011-06-09

Cyclopropyl amines as modulators of the histamine Hreceptor

#537
20110136735
2011-06-09

Cyclohexane derivatives and uses thereof

#538
20110092751
2011-04-21

Process for the preparation of delmopinol and derivatives thereof

#539
20110077247
2011-03-31

Class of histone deacetylase inhibitors

#540
20110071125
2011-03-24

SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY

#541
20110065689
2011-03-17

Piperazine PDE4 inhibitors and uses thereof

#542
20110065688
2011-03-17

Therapeutic piperazines

#543
20110059969
2011-03-10

PIPERAZINES AS ANTI-OBESITY AGENTS

#544
20110059958
2011-03-10

Morpholinone compounds as factor IXa inhibitors

#545
20110053901
2011-03-03

ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE

#546
20110046135
2011-02-24

NEW COMPOUNDS I

#547
20110046122
2011-02-24

3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines

#548
20110039819
2011-02-17

SUBSTITUTED PHENOXYBENZAMIDES

#549
20110028462
2011-02-03

Niacin Receptor Agonists, compositions Containing Such Compounds and Methods of Treatment

#550
20110021520
2011-01-27

Oxazine derivatives and their use in the treatment of neurological disorders

#551
20110014186
2011-01-20

Arylsulfonamide-based matrix metalloprotease inhibitors

#552
20100324056
2010-12-23

Biphenyl amides as P2Xand P2Xantagonists

#553
20100317697
2010-12-16

Renin Inhibitors

#554
20100305131
2010-12-02

Substituted aminopropionic derivatives as neprilysin inhibitors

#555
20100305072
2010-12-02

Substituted tetracycline compounds

#556
20100297077
2010-11-25

Aryl potassium channel blockers and uses thereof

#557
20100292447
2010-11-18

METHOD AND AGENT FOR REFOLDING PROTEINS

#558
20100280243
2010-11-04

PROCESS FOR PRODUCTION OF 4- (SUBSTITUTED PHENYL) HEXAHYDROPYRIDO [2,1-C] [1,4] OXAZIN-6-ONE

#559
20100280018
2010-11-04

Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors

#560
20100279996
2010-11-04

NOVEL ANALGESIC THAT BINDS FILAMIN A

#561
20100273842
2010-10-28

Amine derivatives having NPY Y5 receptor antagonistic activity and the uses thereof

#562
20100273785
2010-10-28

2,5-disubstituted arylsulfonamide CCR3 antagonists

#563
20100273739
2010-10-28

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#564
20100267945
2010-10-21

Amine derivative having NPY Y5 receptor antagonistic activity

#565
20100267738
2010-10-21

Amide and amidine derivatives and uses thereof

#566
20100256150
2010-10-07

Cyclic hydroxylamine as psychoactive compounds

#567
20100240644
2010-09-23

Morpholine derivative

#568
20100222581
2010-09-02

Isophthalates as beta-secretase inhibitors

#569
20100222579
2010-09-02

Process for the preparation of delmopinol and derivatives thereof

#570
20100216796
2010-08-26

N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS

#571
20100210640
2010-08-19

BENZAMIDE DERIVATIVES, THEIR PREPARATION AND USES IN MEDICINE THEREOF

#572
20100197564
2010-08-05

DIARYL MORPHOLINES AS CB1 MODULATORS

#573
20100190791
2010-07-29

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

#574
20100168080
2010-07-01

NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS

#575
20100167926
2010-07-01

3-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES

#576
20100160327
2010-06-24

Modified malonate derivatives

#577
20100137316
2010-06-03

Morpholine Compounds, Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Compositions, and Methods Of Use Thereof

#578
20100130485
2010-05-27

Cyclopropyl amines as modulators of the histamine Hreceptor

#579
20100130471
2010-05-27

Renin Inhibitors

#580
20100113451
2010-05-06

NOVEL PREVENTIVE AND/OR THERAPEUTIC AGENT FOR DIABETIC NEUROPATHY

#581
20100104629
2010-04-29

CATIONIC LIPIDS AND USES THEREOF

#582
20100093713
2010-04-15

BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE

#583
20100093695
2010-04-15

Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors

#584
20100087437
2010-04-08

Potassium channel blockers

#585
20100087428
2010-04-08

Potassium channel blockers

#586
20100087425
2010-04-08

Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors

#587
20100087410
2010-04-08

Aryl aniline derivatives as βadrenergic receptor agonists

#588
20100087326
2010-04-08

HETEROCYLIC COMPOUNDS CONTAINING THE MORPHOLINE NUCLEUS THEIR PREPARATION AND USE

#589
20100069389
2010-03-18

NOVEL FORMS OF REBOXETINE

#590
20100069328
2010-03-18

Ortho-aminoanilides for the treatment of cancer

#591
20100063044
2010-03-11

SUBSTITUTED ANILINE DERIVATIVES

#592
20100063027
2010-03-11

Amine derivative having NPY Y5 receptor antagonistic activity

#593
20100035996
2010-02-11

GLUCOSE METABOLISM STIMULATING AGENT

#594
20100035873
2010-02-11

Diaryl Compounds and Uses Thereof

#595
20100029644
2010-02-04

Compounds which modulate the CB2 receptor

#596
20100016291
2010-01-21

MTP inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives

#597
20090318499
2009-12-24

Compounds having analgesic and/or immunostimulant activity

#598
20090312329
2009-12-17

Cyclic hydroxylamine as psychoactive compounds

#599
20090291953
2009-11-26

PHARMACEUTICAL SALTS OF REBOXETINE

#600
20090291945
2009-11-26

CYSTEINE PROTEASE INHIBITORS